Basic Materials / Specialty ChemicalsBSE
$626.70
+8.30 (+1.34%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $23.8M · quality 42.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
61/100
B
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$42.2B
P/E
30.5x
↑EV/EBITDA
19.3x
↑ROE
13.7%
↑Gross Margin
37.3%
↑Debt/Equity
0.37
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+10.6%
FCF CAGR
-40.1%
FCF margin
0.2%
FCF / Net income
0.02x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $14.41B · net income $1.27B · FCF $23.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $14.41B | $14.41B | $12.09B | $13.88B | $10.66B |
| Net Income | $1.27B | $1.27B | $1.01B | $1.37B | $813.9M |
| EBITDA | $2.31B | $2.31B | $2.05B | $2.34B | $1.57B |
| EPS | 19.23 | 19.23 | 15.90 | 22.86 | 13.63 |
| Gross Margin | 37.3% | 37.3% | 37.1% | 35.5% | 36.2% |
| Operating Margin | 13.3% | 13.3% | 14.0% | 14.8% | 12.6% |
| Net Margin | 8.8% | 8.8% | 8.4% | 9.8% | 7.6% |
| Balance Sheet | |||||
| Debt/Equity | 0.37 | 0.37 | 0.34 | 0.73 | 1.04 |
| Current Ratio | 1.60 | 1.60 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $23.8M | $23.8M | $-528.5M | $168.8M | $110.6M |
| Returns | |||||
| ROE | 13.7% | 13.7% | 14.4% | 33.0% | 29.4% |
| Valuation | |||||
| P/E | 30.53 | 30.53 | 20.91 | 12.72 | 23.80 |
| EV/EBITDA | 19.32 | 19.32 | 11.47 | 8.70 | 14.15 |
| P/B | 4.45 | 4.45 | 3.01 | 4.19 | 7.00 |
| Growth & Yield | |||||
| Revenue Growth | 19.2% | 19.2% | -12.9% | 30.2% | — |
| EPS Growth | 20.9% | 20.9% | -30.4% | 67.7% | — |
| Dividend Yield | 0.1% | 0.1% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
42.5%
EPS terminal req.
$55.61
Spread vs growth
-21.5%
5Y implied EPS CAGR
28.5%
EPS terminal req.
$67.29
Spread vs growth
-7.5%
10Y implied EPS CAGR
18.9%
EPS terminal req.
$108.37
Spread vs growth
2.1%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+18.2%
Start / end P/E
33.4x → 32.6x
EPS bridge
15.90 → 19.23
Residual
-0.5%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.